Sam's News — health — 2026-09-18¶
Health¶
7.5 Restoring Brain Protein Menin Reverses Signs of Aging in Mice¶
Scientists found that restoring the brain protein Menin reversed multiple aging signs in mice, including inflammation, cognitive decline, and physical deterioration. The mechanism involves a disrupted chemical pathway where Menin loss reduces D-serine, an amino acid critical for learning and memory.
- Menin declines with age in the ventromedial hypothalamus, a brain region controlling metabolism
- Menin loss triggers lower bone mass, thinner skin, cognitive decline, and shorter lifespan
- D-serine, an amino acid, mediates the connection between Menin and cognitive function
- Published March 16, 2023, in PLOS Biology by researchers at Xiamen University
Sources: ScienceDaily AI Web Searched, ScienceDaily — Health RSS, ScienceDaily — Fitness RSS, ScienceDaily — Nutrition RSS
7 Scientists Identify Cells That Survive Programmed Death and Rebuild Damaged Tissue¶
Weizmann Institute scientists identified a population of cells that can initiate apoptosis, survive it, and then rebuild damaged tissue with increased resistance to future injury. The discovery reveals an unexpected role for caspase enzymes in cell survival rather than just cell death.
- Caspase enzymes can help cells survive programmed death and become more resistant to injury
- Mechanism enables rapid tissue repair observed in compensatory proliferation
- Published in Nature Communications
- Potential concern: cancer cells may exploit this survival mechanism for aggressive regrowth
Sources: ScienceDaily AI Web Searched, ScienceDaily — Health RSS
6.5 Newer Blood Thinners Show Cognitive Benefits for Alzheimer's Patients¶
Patients with Alzheimer's disease taking NOACs (newer blood thinners) experienced slower cognitive decline than those on warfarin or no blood thinners.
Sources: ScienceDaily RSS, ScienceDaily — Health RSS
Medical Innovation¶
7.5 Kidney Transplant Breakthrough Enables Donation for Previously Impossible Case¶
A Medical University of Vienna team successfully transplanted a kidney into a 37-year-old patient with zero compatible donors by using teclistamab, a cancer drug, to reduce antibodies against foreign structures. The patient had waited 12+ years with severe HLA sensitization.
- Patient: 37-year-old, dialysis-dependent, zero probability of donor match (cPRA = 0)
- Prior transplants: 2, both failed, causing HLA sensitization
- Treatment: teclistamab (cancer medicine) for 31 weeks
- Mechanism: eliminates antibody-producing cells in blood and bone marrow
- Publication: New England Journal of Medicine; first transplant use of teclistamab
Sources: Medical University of Vienna / Medical News AI Web Searched, News-Medical Web Search
6.5 University of Missouri Launches First In-Person Clinical Trial for Nuclear Medicine Device¶
University of Missouri begins patient testing of a novel nuclear medicine diagnostic or treatment device.
Sources: Show Me Mizzou Web Search
Humanitarian¶
7 Sudan Civil War Disrupts Medical Treatment Access¶
Sudan's ongoing civil war has crippled healthcare access for millions, forcing cancer patients and those with chronic illnesses to undertake dangerous hundred-mile journeys for treatment previously available locally. With 205 hospital attacks since 2023 and 13 million people displaced, international aid cuts have devastated an already fragile health system.
- 13 million people displaced by conflict—world's largest displacement crisis
- 205 attacks on healthcare facilities since war began in 2023
- Cancer patients traveling hundreds of miles from cities like Khartoum and Nyala for treatment
- One permanent surgeon serves entire Nuba Mountains region
Sources: STAT AI Web Searched, STAT News RSS
Medical Research¶
7 Emergency Medicine Researchers Report Breakthrough in New England Journal of Medicine¶
A Phase 3 clinical study published in the New England Journal of Medicine found that azithromycin, an antibiotic, did not reduce wheezing-related symptoms better than placebo in preschool children with acute moderate-to-severe wheezing in emergency settings.
- Study: AZ-SWED (Azithromycin Therapy in Preschoolers with Severe Wheezing)
- Finding: azithromycin no more effective than placebo for symptom reduction
- Population: preschool-age children, moderate-to-severe acute wheezing
- Funding: National Heart, Lung, and Blood Institute (NHLBI)
- Publication context: NEJM receives 16,000 submissions/year, accepts ~5%
Sources: University of Arizona College of Medicine – Tucson AI Web Searched, College of Medicine - Tucson Web Search
6.5 Mayo Clinic 2024 Research Breakthroughs Highlight Year of Medical Progress¶
Mayo Clinic researchers announce ten major medical discoveries advancing treatment and diagnostic approaches.
Sources: Mayo Clinic News Network Web Search
6.5 Stanford Medicine 2025 Scientific Advancements Overview¶
Stanford Medicine researchers highlight major scientific achievements and medical breakthroughs from the past year.
Sources: Stanford Medicine Web Search
AI in Healthcare¶
6.5 AI's True Healthcare Impact: Expanding Access to Proven Treatments¶
Healthcare experts argue that AI's most significant value lies in scaling delivery of established effective care rather than discovering new treatments.
Sources: nyas.org Web Search